StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.43−0.05 (-10.13%)

Close on Oct 19, 2026Market cap $965.06KP/E –Yield –

Onconetix shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Onconetix's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 2803.0% from the year before. The highest annual figure on record is 1M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+2803.0%
FY2024Dec 31, 20240M+541.8%
FY2023Dec 31, 20230M+39.5%
FY2022Dec 31, 20220M+283.5%
FY2021Dec 31, 20210M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262M+19654.9%
Q1 FY2026Mar 31, 20261M+1370.1%
Q4 FY2025Dec 31, 20252M+10107.4%
Q3 FY2025Sep 30, 20251M+21429.9%
Q2 FY2025Jun 30, 20250M+74.3%
Q1 FY2025Mar 31, 20250M+661.4%
Q3 FY2024Sep 30, 20240M+198.2%
Q2 FY2024Jun 30, 20240M+36.7%
Q1 FY2024Mar 31, 20240M+54.5%
Q4 FY2023Dec 31, 20230M+59.2%
Q3 FY2023Sep 30, 20230M+176.3%
Q4 FY2022Dec 31, 20220M+407.5%
Q3 FY2022Sep 30, 20220M+348.1%
Q2 FY2022Jun 30, 20220M+274.9%
Q1 FY2022Mar 31, 20220M–
Q4 FY2021Dec 31, 20210M–
Q3 FY2021Sep 30, 20210M–
Q2 FY2021Jun 30, 20210M–

More Onconetix figures

See a number that looks wrong?